UltiMed improves patient comfort with new UltiCare® Micro 4mm x 32G pen needle

  • March 19, 2012
  • Corporate News

St. Paul, MN – March 19, 2012 – UltiMed announces the launch of the new 4mm x 32G UltiCare® Micro pen needle, their shortest, thinnest pen needle providing a more comfortable injection for patients living with diabetes.

The UltiCare® Micro offers all the comfort features of the leading pen needle at a lower cost to pharmacists and a less painful injection experience to the patient.

UltiMed is one of only a few pen needle manufacturers, and follows all ISO standards for pen needles, providing added quality assurance testing other pen needle distributors cannot.

The new Micro 4mm x 32G pen needle is compatible with all pens sold in the U.S. and is available in a easy to dispense 50-count box or 100-count UltiGuard® Safe Pack that combines pen needles and an approved sharps container all in one system.

About UltiMed, Inc.
UltiMed, Inc., headquartered in St. Paul, Minnesota is a manufacturer diabetic drug delivery devices and specialty safety syringe devices, including insulin syringes, pen needles and other specialty syringes for domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world.

If you’d like more information about this topic, or to schedule an interview with Holly Hartshorn, please call Holly at (651) 291-7909, X211 or e-mail at h.hartshorn@ulticare.com

UltiMed, Inc. begins manufacturing pen needles in the U.S.

  • November 11, 2011
  • Corporate News

St. Paul, MN – November 11, 2011 – UltiMed, Inc. announced the beginning of the manufacture of pen needles at its DeSmet, South Dakota facilities.

Pen needles are used on pen injectors. Pen injectors are designed for more convenient injection of insulin and other self injected medications. Pen injection is the most popular means of administrating medications in many of the world’s developed areas including Europe, Canada and Asia. Pen injection is increasing being used by self injectors in the United States.

UltiMed designed its manufacturing facility in DeSmet in anticipation of a large and rapid growth in pen needle demand. Therefore future capacity additions to UltiMed’s DeSmet pen needle production can be done rapidly and efficiently.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.